LAMPERT MARK N

See Explanation of Responses at CTI BIOPHARMA CORP · on record since Jun 28, 2023
Former 10% Owner at POINT Biopharma Global Inc. · on record since Dec 20, 2023
10% owner at enGene Therapeutics Inc. · on record since Nov 13, 2023
10% owner at POINT Biopharma Global Inc. · on record since Nov 6, 2023
See Remarks; Former 10% Owner at Rain Oncology Inc. · on record since Apr 27, 2021
10% owner at Allakos Inc. · on record since Jan 26, 2024
10% owner at Xenon Pharmaceuticals Inc. · on record since Sep 12, 2016
See Explanation of Responses at TF FINANCIAL CORP · on record since Oct 31, 2024
See Explanation of Responses at PALVELLA THERAPEUTICS, INC. · on record since Dec 17, 2024
See Explanation of Responses at 4D Molecular Therapeutics, Inc. · on record since Nov 13, 2024
See Explanation of Responses at Olema Pharmaceuticals, Inc. · on record since Dec 4, 2024
See Explanation of Responses at KENT FINANCIAL SERVICES INC · on record since Dec 28, 2011
Director at IMMUNIC, INC. · on record since Feb 27, 2026
See Explanation of Responses at IMMUNIC, INC. · on record since Feb 27, 2026
10% owner at Rain Oncology Inc. · on record since May 25, 2021
10% owner at AVIGEN INC \DE · on record since Jan 21, 2009
10% owner at DYNAVAX TECHNOLOGIES CORP · on record since Jul 29, 2009
10% owner at · on record since Sep 24, 2009
10% owner at · on record since Sep 21, 2009
10% owner at · on record since Jul 16, 2009
10% owner at · on record since Sep 10, 2009
10% owner at · on record since Dec 24, 2009
10% owner at · on record since Dec 24, 2009
10% owner at · on record since Oct 23, 2009
10% owner at · on record since Mar 29, 2010
10% owner at · on record since Apr 21, 2010
10% owner at · on record since Mar 23, 2011
Director at · on record since Apr 2, 2026
10% owner at · on record since Apr 2, 2026
10% owner at · on record since Jun 29, 2011
10% owner at · on record since Aug 22, 2011
10% owner at · on record since Sep 9, 2011
10% owner at · on record since Oct 7, 2011
10% owner at · on record since Dec 5, 2011
Director at · on record since Oct 21, 2003
10% owner at · on record since Oct 21, 2003
See Explanation of Responses at · on record since Feb 10, 2012
Director at · on record since Dec 30, 2016
10% owner at · on record since Dec 30, 2016
10% owner at · on record since Aug 31, 2012
10% owner at · on record since May 15, 2013
10% owner at · on record since May 18, 2026
10% owner at · on record since Jun 7, 2013
See Explanation of Responses at · on record since Mar 26, 2014
See Explanation of Responses at · on record since Mar 25, 2014
10% owner at · on record since Feb 10, 2014
See Explanation of Responses at · on record since Jul 16, 2014
See Explanation of Responses at · on record since Jul 10, 2014
See Explanation of Responses at · on record since Aug 21, 2015
10% owner at · on record since Dec 14, 2015
See Explanation of Responses at · on record since Nov 5, 2015
Director at · on record since Jun 27, 2016
10% owner at · on record since Jun 22, 2017
10% owner at · on record since May 11, 2017
10% owner at · on record since Sep 29, 2017
See Explanation of Responses at · on record since Jul 18, 2017
10% owner at · on record since Nov 27, 2017
10% owner at · on record since Dec 8, 2017
10% owner at · on record since Nov 26, 2018
10% owner at · on record since Nov 9, 2018
10% owner at · on record since Jul 1, 2019
10% owner at · on record since Oct 31, 2019
10% owner at · on record since Dec 12, 2019
10% owner at · on record since Jan 21, 2020
10% owner at · on record since Jun 22, 2020
10% owner at · on record since Aug 20, 2020
See Explanation of Responses at · on record since Dec 28, 2020
10% owner at · on record since Dec 28, 2020
10% owner at · on record since Nov 20, 2020
See Explanation of Responses at · on record since Nov 20, 2020
See Explanation of Responses at · on record since Nov 13, 2020
10% owner at · on record since Oct 5, 2020
See Explanation of Responses at · on record since Feb 19, 2021
See Explanation of Responses at · on record since Feb 18, 2021
See Explanation of Responses at · on record since Feb 4, 2021
10% owner at · on record since Nov 8, 2021
10% owner at · on record since Jan 10, 2022
10% owner at · on record since Feb 7, 2022
10% owner at · on record since Jun 27, 2022
Director at · on record since May 20, 2022
Director at · on record since Jun 14, 2022
10% owner at · on record since Jul 21, 2022
Director at · on record since Aug 11, 2022
10% owner at · on record since Dec 22, 2022
Director at · on record since Nov 10, 2022
Director at · on record since Jan 13, 2023
See Remarks and Footnotes at · on record since Aug 25, 2020
10% owner at · on record since Feb 13, 2023
10% owner at · on record since Oct 5, 2026

Insider trading activity of LAMPERT MARK N

Transactions on record: 224; since Oct 21, 2003

Open-market buys: 102; $66.1M

Open-market sells: 28; $102.5M

Companies traded: 26; last filing Jun 20, 2023

Figures computed from official regulatory filings — .

Companies where LAMPERT MARK N has traded

11 tx · $19.6M · Jun 20, 2023
38 tx · $71M · Aug 11, 2022
27 tx · $19.1M · Apr 27, 2021
6 tx · $11.7M · Apr 1, 2021
12 tx · Dec 28, 2020
8 tx · $18.6M · Dec 20, 2019
6 tx · $1.2M · Nov 22, 2019
9 tx · $113.8K · Oct 31, 2019
12 tx · $81.6K · Mar 29, 2018
6 tx · $106.7K · Jun 1, 2017
1 tx · $2.3M · Jul 10, 2014
13 tx · $358.3K · Jul 3, 2014
7 tx · $357.4K · Feb 19, 2014
2 tx · $426.3K · Aug 12, 2013

Track record of LAMPERT MARK N

Statistical track record

Free account

Open-market buys: 106

Last buy: Mar 30, 2021

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of LAMPERT MARK N

Co-insiders of LAMPERT MARK N

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Kymera Therapeutics, Inc.Listing on record	Jun 20, 2023	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	OtherD (derivative)	-2,280	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Other	3,754,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Sell	-1,289,434	6.12 USD	$7.9M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Sell	-3,850,803	6.12 USD	$23.6M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Other	2,426,666	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Sell	-469,040	6.12 USD	$2.9M		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Sell	-2,890,723	6.12 USD	$17.7M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Other	1,519,999	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	OtherD (derivative)	-1,024	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Other	682,666	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	OtherD (derivative)	-3,640	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	OtherD (derivative)	-5,631	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Other	553,359	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Other	115,293	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Award	546,346	17.00 USD	$9.3M		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Other	134,515	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	OtherD (derivative)	-837,397	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Award	38,858	15.93 USD	$619K		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	OtherD (derivative)	-134,515	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Award	10,876	14.90 USD	$162.1K		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Award	14,790	14.90 USD	$220.4K		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Award	53,303	15.93 USD	$849.1K		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Other	1,068,554	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	OtherD (derivative)	-84,350	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Kymera Therapeutics, Inc.Listing on record	Jun 20, 2023	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	OtherD (derivative)	-2,280	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Other	3,754,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Sell	-1,289,434	6.12 USD	$7.9M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Sell	-3,850,803	6.12 USD	$23.6M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Other	2,426,666	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Sell	-469,040	6.12 USD	$2.9M		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Sell	-2,890,723	6.12 USD	$17.7M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Other	1,519,999	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	OtherD (derivative)	-1,024	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	Other	682,666	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	OtherD (derivative)	-3,640	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Aug 11, 2022	OtherD (derivative)	-5,631	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Other	553,359	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Other	115,293	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Award	546,346	17.00 USD	$9.3M		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Other	134,515	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	OtherD (derivative)	-837,397	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Award	38,858	15.93 USD	$619K		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	OtherD (derivative)	-134,515	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Award	10,876	14.90 USD	$162.1K		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Award	14,790	14.90 USD	$220.4K		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Award	53,303	15.93 USD	$849.1K		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	Other	1,068,554	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Apr 27, 2021	OtherD (derivative)	-84,350	—	n/a (No price was disclosed in the filing)		SEC